Kaiyan Liu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Induced Pluripotent Stem Cells

Radiation Induced

Top Venues

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)